Preview Mode Links will not work in preview mode

Feb 9, 2024

 

This week, we revisit our interview with Renee Ryan. Renee has 25 years of building category-creating healthcare companies. She was most recently the CEO of Cala. Prior to Cala she led the health technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs.  Renee currently sits on the boards of Cala, Neuropace and RefleXion Medical.